Patricia Vella Bonanno

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 346 citations · Full text

The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications

Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek et al. · PharmacoEconomics · 2017 · 117 citations · Full text

Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries

Tomasz Bochenek, Vafa Abilova, Ali Alkan et al. · Frontiers in Pharmacology · 2018 · 102 citations · Full text

Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

Brian Godman, Andrew Hill, Steven Simoens et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 71 citations · Full text

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 67 citations · Full text